Liver disease and the vascular system (LiVas)
Featured projects
-
IMMunothrombosis Mechanisms and INnovative bioengineered model in Portal Vein Thrombsosis (IMMINENT)
Principal investigator: Virginia Hernandez Gea.Funder: La Caixa.Duration: 01/12/2026 - 30/11/2029Recreating the Human Portal Circulation with Portal Vein Organoids (PORTALOID)
Principal investigator: Virginia Hernandez Gea.Funder: Fundación BBVA.Duration: 31/07/2026 - 31/01/2028Exploring tDCS-EEG and BIS for Risk Stratification and Therapeutic Modulation in Post-TIPS Hepatic Encephalopathy
Principal investigator: Anna Baiges Aznar.Funder: Instituto de Salud Carlos III.Code: PI25/00914.Duration: 01/01/2026 - 31/12/2028CB/06/04/0026
Principal investigator: Juan Carlos García Pagán.Funder: Instituto de Salud Carlos III - CIBERehd.Duration: 01/01/2026 - 31/12/2026COST Action CA23146: European Vascular liver disease network
Principal investigator: Virginia Hernandez Gea.Funder: COST | European Cooperation in Science and Technology.Duration: 01/11/2024 - 01/10/2029Decoding the Endothelial cell intrinsic mechanisms causing portosinusoidal hyperTENSION (EndoTENSION)
Principal investigator: Virginia Hernandez Gea.Funder: La Marató de TV3.Code: La Marató 2022 - 202319-31.Duration: 01/06/2024 - 31/05/2026Enfermedades Vasculares Portosinusoidales: Identificacion de nuevas dianas terapeuticas y estratificación del riesgo
Principal investigator: Virginia Hernandez Gea.Funder: Instituto de Salud Carlos III.Code: PI23/00997.Duration: 01/01/2024 - 31/12/2026Nuevas herramientas diagnósticas, pronósticas y de evaluación de la respuesta al tratamiento de pacientes con enfermedades vasculares del hígado
Principal investigator: Juan Carlos García Pagán.Funder: Instituto de Salud Carlos III.Code: PI23/01102.Duration: 01/01/2024 - 31/12/2026PortoSinusoidal Vascular Disease: Estratificacion de riesgo y Enfoques terapéuticos (RiTA)
Principal investigator: Virginia Hernandez Gea, Mariona Graupera.Funder: Instituto de Salud Carlos III.Code: FIS_AC23 (CE_ERANET).Duration: 01/01/2024 - 31/12/2026Expandiendo horizontes en el tratamiento de la encefalopatía hepática post-TIPS
Principal investigator: Anna Baiges Aznar.Funder: Instituto de Salud Carlos III (ISCIII).Code: PI21/00131.Duration: 01/01/2022 - 31/12/2024Major founders
The research of this group can be carried out thanks to the funders.
